Clinical Trials Browser

Phase 2 × Breast Neoplasms × Sunitinib × Clear all

NCT00482755 2024-02-12

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00270413 2022-11-22

SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT00513695 2019-08-07

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

Phase 2 Completed

68 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00824538 2018-04-05

Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow

Phase 2 Terminated

13 enrolled 6 charts

Breast Neoplasms

NCT01176799 2016-06-22

Randomized Study of Doxorubicin and Cyclophosphamide With or Without Intermittent Sunitinib in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor

Phase 2 Unknown

Breast Neoplasms

NCT01803503 2016-06-22

Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors

Phase 2 Unknown

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Stomach Neoplasms

NCT02790580 2016-06-06

Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib in Breast Cancer Patients

Phase 2 Unknown

Breast Neoplasms

NCT00570908 2014-09-18

Brain Mets - Capecitabine Plus Sunitinib and WBRT

Phase 2 Terminated

12 enrolled 7 charts

Brain Neoplasms, Breast Neoplasms

NCT00662025 2013-05-27

Study Of Sunitinib With Capecitabine In Breast Cancer

Phase 2 Completed

63 enrolled 24 charts

Breast Neoplasms

NCT00246571 2012-07-12

Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer

Phase 2 Completed

217 enrolled 24 charts

Breast Neoplasms

NCT00471276 2011-07-25

Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer

Phase 2 Completed

83 enrolled 26 charts

Breast Neoplasms

NCT00243503 2011-07-22

Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer

Phase 2 Completed

60 enrolled 18 charts

Breast Neoplasms

NCT00434356 2009-12-03

A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B)

Phase 2 Terminated

46 enrolled 8 charts

Breast Neoplasms

NCT00078000 2008-11-26

A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.

Phase 2 Completed

Breast Neoplasms